Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On February 24, 2026, Werewolf Therapeutics, Inc. issued a press release announcing that it plans to explore strategic alternatives and has engage
. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated February 24, 2026 104 Cover Page Interactive Data File (embe